Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Maosi Wang"'
Autor:
Keqi Wang, Yongyan Chen, Shuo Gao, Maosi Wang, Mengmeng Ge, Qian Yang, Mingkai Liao, Lin Xu, Junjie Chen, Zhiping Zeng, Haifeng Chen, Xiao-kun Zhang, Ting Lin, Hu Zhou
Publikováno v:
Acta Pharmaceutica Sinica B, Vol 11, Iss 2, Pp 442-455 (2021)
Although different types of drugs are available for postmenopausal osteoporosis, the limitations of the current therapies including drug resistances and adverse effects require identification of novel anti-osteoporosis agents. Here, we defined that n
Externí odkaz:
https://doaj.org/article/87c11355d3e84c7cb1668c18e2c878e2
Autor:
Qian Yang, Lin Xu, Mingkai Liao, Hai-Feng Chen, Mengmeng Ge, Junjie Chen, Zhiping Zeng, Ting Lin, Keqi Wang, Xiao-kun Zhang, Yongyan Chen, Hu Zhou, Maosi Wang, Shuo Gao
Publikováno v:
Acta Pharmaceutica Sinica B, Vol 11, Iss 2, Pp 442-455 (2021)
Although different types of drugs are available for postmenopausal osteoporosis, the limitations of the current therapies including drug resistances and adverse effects require identification of novel anti-osteoporosis agents. Here, we defined that n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c7a41cb88487cc9f9f29061553721a0
https://doi.org/10.1016/j.apsb.2020.09.012
https://doi.org/10.1016/j.apsb.2020.09.012
Autor:
Keqi, Wang, Yongyan, Chen, Shuo, Gao, Maosi, Wang, Mengmeng, Ge, Qian, Yang, Mingkai, Liao, Lin, Xu, Junjie, Chen, Zhiping, Zeng, Haifeng, Chen, Xiao-Kun, Zhang, Ting, Lin, Hu, Zhou
Publikováno v:
Acta Pharmaceutica Sinica. B
Although different types of drugs are available for postmenopausal osteoporosis, the limitations of the current therapies including drug resistances and adverse effects require identification of novel anti-osteoporosis agents. Here, we defined that n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1dab2fa8ef2020b6879e1dfc3341a8bf
https://pubmed.ncbi.nlm.nih.gov/33643823
https://pubmed.ncbi.nlm.nih.gov/33643823
Autor:
Ying Su, Zhiping Zeng, Xiao-kun Zhang, Weidong Zhang, Gaoang Ren, Ce Shang, Bao Wei, Maosi Wang, Hu Zhou
Publikováno v:
Molecular pharmaceutics. 16(2)
Bexarotene, an agonist of retinoid X receptor alpha (RXRα), has been shown to increase the expression of apoE, ABCA1, and ABCG1 by activating RXR/LXR and RXR/PPAR heterodimers, resulting in amyloid β (Aβ)-protein clearance in the brain of an Alzhe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e60a8adda774e2415b859a311c9b3c5
https://pubmed.ncbi.nlm.nih.gov/29995422
https://pubmed.ncbi.nlm.nih.gov/29995422
Publikováno v:
Proceedings of the 2017 3rd International Conference on Social Science and Higher Education.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c2dbc90d4db6a3d2fd30f2b1fbc19e9d
https://doi.org/10.2991/icsshe-17.2017.146
https://doi.org/10.2991/icsshe-17.2017.146